We found higher serum TGF-β1 levels in pre-radiotherapeutic NPC patients compared with healthy controls, and the levels were decreased post radiotherapy (Figure S2), implying a positive role of TGF-β1 in the clinical progression in NPC patients. The gene discussed is TGFB1; the disease is nasopharyngeal carcinoma.